-
1
-
-
33646108135
-
Trp53 loss during in vitro selection contributes to acquired Ara-C resistance in acute myeloid leukemia
-
Yin B, Kogan SC, Dickins RA, Lowe SW, Largaespada DA. Trp53 loss during in vitro selection contributes to acquired Ara-C resistance in acute myeloid leukemia. Exp Hematol 2006; 34: 631-641.
-
(2006)
Exp Hematol
, vol.34
, pp. 631-641
-
-
Yin, B.1
Kogan, S.C.2
Dickins, R.A.3
Lowe, S.W.4
Largaespada, D.A.5
-
2
-
-
9244234326
-
Association between single nucleotide polymorphisms in deoxycytidine kinase and treatment response among acute myeloid leukaemia patients
-
Shi JY, Shi ZZ, Zhang SJ, Zhu YM, Gu BW, Li G et al. Association between single nucleotide polymorphisms in deoxycytidine kinase and treatment response among acute myeloid leukaemia patients. Pharmacogenetics 2004; 14: 759-768.
-
(2004)
Pharmacogenetics
, vol.14
, pp. 759-768
-
-
Shi, J.Y.1
Shi, Z.Z.2
Zhang, S.J.3
Zhu, Y.M.4
Gu, B.W.5
Li, G.6
-
3
-
-
0034663307
-
High incidence of alternatively spliced forms of deoxycytidine kinase in patients with resistant acute myeloid leukemia
-
Veuger MJ, Honders MW, Landegent JE, Willemze R, Barge RM. High incidence of alternatively spliced forms of deoxycytidine kinase in patients with resistant acute myeloid leukemia. Blood 2000; 96: 1517-1524.
-
(2000)
Blood
, vol.96
, pp. 1517-1524
-
-
Veuger, M.J.1
Honders, M.W.2
Landegent, J.E.3
Willemze, R.4
Barge, R.M.5
-
4
-
-
67649449952
-
Defective expression of deoxycytidine kinase in cytarabine-resistant acute myeloid leukemia cells
-
Song JH, Kim SH, Kweon SH, Lee TH, Kim HJ, Kim HJ et al. Defective expression of deoxycytidine kinase in cytarabine-resistant acute myeloid leukemia cells. Int J Oncol 2009; 34: 1165-1171.
-
(2009)
Int J Oncol
, vol.34
, pp. 1165-1171
-
-
Song, J.H.1
Kim, S.H.2
Kweon, S.H.3
Lee, T.H.4
Kim, H.J.5
Kim, H.J.6
-
5
-
-
41149092987
-
The inhibitory effects of disabled-2 (Dab2) on Wnt signaling are mediated through Axin
-
Jiang Y, Prunier C, Howe PH. The inhibitory effects of disabled-2 (Dab2) on Wnt signaling are mediated through Axin. Oncogene 2008; 27: 1865-1875.
-
(2008)
Oncogene
, vol.27
, pp. 1865-1875
-
-
Jiang, Y.1
Prunier, C.2
Howe, P.H.3
-
6
-
-
19944431879
-
Expression of IFITM1 in chronic myeloid leukemia patients
-
Akyerli CB, Beksac M, Holko M, Frevel M, Dalva K, Ozbek U et al. Expression of IFITM1 in chronic myeloid leukemia patients. Leuk Res 2005; 29: 283-286.
-
(2005)
Leuk Res
, vol.29
, pp. 283-286
-
-
Akyerli, C.B.1
Beksac, M.2
Holko, M.3
Frevel, M.4
Dalva, K.5
Ozbek, U.6
-
7
-
-
57149094865
-
An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma
-
Kongkham PN, Northcott PA, Ra YS, Nakahara Y, Mainprize TG, Croul SE et al. An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma. Cancer Res 2008; 68: 9945-9953.
-
(2008)
Cancer Res
, vol.68
, pp. 9945-9953
-
-
Kongkham, P.N.1
Northcott, P.A.2
Ra, Y.S.3
Nakahara, Y.4
Mainprize, T.G.5
Croul, S.E.6
-
8
-
-
64349091540
-
Annexins in human breast cancer: Possible predictors of pathological response to neoadjuvant chemotherapy
-
Chuthapisith S, Bean BE, Cowley G, Eremin JM, Samphao S, Layfield R et al. Annexins in human breast cancer: possible predictors of pathological response to neoadjuvant chemotherapy. Eur J Cancer 2009; 45: 1274-1281.
-
(2009)
Eur J Cancer
, vol.45
, pp. 1274-1281
-
-
Chuthapisith, S.1
Bean, B.E.2
Cowley, G.3
Eremin, J.M.4
Samphao, S.5
Layfield, R.6
|